Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs Duloxetine in MDD
NCT00108979Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Mar 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Mar 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00108979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108979.